These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1148675)

  • 1. Letter: diffuse pulmonary disorder caused by oxyphenbutazone.
    Cameron DC
    Br Med J; 1975 May; 2(5969):500-1. PubMed ID: 1148675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary adverse effects of oxyphenbutazone].
    Lakartidningen; 1977 May; 74(21):2109. PubMed ID: 865186
    [No Abstract]   [Full Text] [Related]  

  • 3. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
    Nayyar KC; Pasricha JS
    Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxyphenbutazone-induced goitre.
    Lane RJ; Clark F; McCollum JK
    Postgrad Med J; 1977 Feb; 53(616):93-5. PubMed ID: 141661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreas irritation caused by oxyphenbutazone (Tanderil)].
    van Dijk E
    Ned Tijdschr Geneeskd; 1984 Jan; 128(1):45. PubMed ID: 6694768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreas irritation caused by oxyphenbutazone (Tanderil)].
    Versteegh MI; Vijverberg PL; van Dijk HA
    Ned Tijdschr Geneeskd; 1983 Oct; 127(42):1924-5. PubMed ID: 6196647
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug reaction from oxyphenbutazone.
    Valsecchi R; Tornaghi A; Falgheri G; Rossi A; Cainelli T
    Contact Dermatitis; 1983 Sep; 9(5):419. PubMed ID: 6226482
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxyphenbutazone-induced parotitis.
    Gross L
    Ann Intern Med; 1969 Jun; 70(6):1229-30. PubMed ID: 5789512
    [No Abstract]   [Full Text] [Related]  

  • 10. Ulcer of the cecum during oxyphenbutazone (tandearil) therapy.
    Debenham GP
    Can Med Assoc J; 1966 May; 94(22):1182-4. PubMed ID: 5934387
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxyphenbutazone (Tanderil) and blood dyscrasia.
    Brownlie BE; Strang PJ
    N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
    Krook G
    Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal of oxyphenbutazone: what about phenylbutazone?
    Biron P
    CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oxyphenbutazone-induced hyperkalemia in selective hypoaldosteronism in adults].
    Merkt J
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1535-6. PubMed ID: 6617511
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myelogenous leukemia. Associated with oxyphenbutazone induced aplastic anemia].
    Bull O; Skobba TJ
    Tidsskr Nor Laegeforen; 1974 Aug; 94(21-22):1319-20. PubMed ID: 4528134
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytopenia and L.E. cells after oxyphenbutazone.
    Handley AJ
    Lancet; 1971 Jan; 1(7692):245-6. PubMed ID: 4099912
    [No Abstract]   [Full Text] [Related]  

  • 18. Fixed eruption due to two unrelated drugs: oxyphenbutazone and tetracycline.
    Bhargava NC; Singh G
    Int J Dermatol; 1981; 20(6):435. PubMed ID: 6455387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oxyphenbutazone and leukemia--statistical aspects].
    Råde L
    Lakartidningen; 1966 Feb; 63(8):733-6. PubMed ID: 5917148
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse interstitial lung disease associated with hypersensitivity to gold salt.
    Bellelli A; Boiardi L; Tumiati B; Brigati C
    Clin Exp Rheumatol; 1985; 3(2):181-2. PubMed ID: 3926364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.